2.6
2023

Omalizumab re-treatment rates in chronic spontaneous urticaria

S. Khan <mailto:"sujoykhan@gmail.com">sujoykhan@gmail.com, S. Sholtysek</mailto:"sujoykhan@gmail.com">
Vol. 52 (No. 4) 2020 July
Letter to the Editor
Show more: Authors information and Publication history
Authors Information

Immunology & Allergy, Queen's Center, Castle Hill Hospital, Cottingham, England

History

:
Published online: 7 May 2020
Accepted: 6 April 2020
Received: 16 March 2020

KEY WORDS
Omalizumab; chronic spontaneous urticaria; urticaria activity score; resistance.
Full text PDF

Table of Content: Vol. 52 (No. 4) 2020 July

Letter to the Editor

Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link?

G. Liccardi<mailto:"gennaro.liccardi@tin.it">gennaro.liccardi@tin.it1, L. Calzetta1,2, M. Milanese3, M.B. Bilò4, M.V. Liccardi5, M.G. Matera6, I. Baiardini7, P. Rogliani1,2</mailto:"gennaro.liccardi@tin.it">
Download PDF

Letter to the Editor

Omalizumab re-treatment rates in chronic spontaneous urticaria

S. Khan <mailto:"sujoykhan@gmail.com">sujoykhan@gmail.com, S. Sholtysek</mailto:"sujoykhan@gmail.com">
Download PDF

Original Article

Tree nuts anaphylaxis in preschool age children

J. Matias <mailto:"angela.gaspar@sapo.pt">angela.gaspar@sapo.pt1, Â. Gaspar2, L. M. Borrego2,3, S. Piedade2, G. Pires2, C. Arêde2, G. Sampaio2, M. Morais-Almeida2</mailto:"angela.gaspar@sapo.pt">
doi: 10.23822/EurAnnACI.1764-1489.128
Download PDF

Original Article

Evolution of Api m10 specific IgE and IgG4 after one year of bee venom immunotherapy

M. C. Pereira Santos mcgalvaos@medicina.ulisboa.pt1,3, T. Lourenço2, E. Pedro2, M. Pereira Barbosa2,3, M. Branco Ferreira2,3
Download PDF

Original Article

Healthcare costs associated with allergic rhinitis, asthma and allergy immunotherapy

F. Tesch<mailto:"denise.kuester@uniklinikum-dresden.de">denise.kuester@uniklinikum-dresden.de1, A. Domdey2, T. S. Grand2, E. Wuestenberg 2, L. Elliott2, J. Schmitt1, D. Küster1</mailto:"denise.kuester@uniklinikum-dresden.de">
doi: 10.23822/EurAnnACI.1764-1489.126
Download PDF

Original Article

Blood or skin: what is best in predicting cow’s milk allergy diagnosis?

A. Castro Neves <mailto:"ananeves6@hotmail.com">ananeves6@hotmail.com1, A. M. Romeira1 , J. G. Marques1,2,3, V. Matos4, P. Leiria-Pinto1,3</mailto:"ananeves6@hotmail.com">
doi: 10.23822/EurAnnACI.1764-1489.123
Download PDF

Review

Asthma and COPD “overlap”: a treatable trait or common several treatable-traits?

J. Gaspar Marques gasparmarques@yahoo.com.br1,2 , M. Lobato1 , P. Leiria-Pinto1,2, N. Neuparth1,2, P. Carreiro Martins1,2
Download PDF

Original Article

Use of a comprehensive diagnostic algorithm for Anisakis allergy in a high seroprevalence Mediterranean setting

I. Brusca ignbr@libero.it1, S. Graci2, M. Barrale1, G. Cammilleri2, M. Zarcone3, R. Onida1, A. Costa2, V. Ferrantelli2, M.D. Buscemi2, C.G. Uasuf4, M. Gjomarkaj4, M. Vazzana5, S.M. La Chiusa1, G. Iacolino1, F. Vitale3, W. Mazzucco3
doi: 10.23822/EurAnnACI.1764-1489.118
Download PDF

Original Article

Prevalence of allergic rhinitis in children with otitis media with effusion

S. Norhafizah, H. Salina, B.S. Goh irenegbs@yahoo.com
doi: 10.23822/EurAnnACI.1764-1489.119
Download PDF

Original Article

Clinical experience of a chronic urticaria referral university center

G. Andrade Coelho Dias gabrielaacdias@gmail.com, F. Cunha Coelho, P. Filippo, D. Lacerda Pedrazzi, A.C. Nogueira Arraes, M.I. Perelló, F. Chigres Kuschnir, E. Costa
Download PDF

Original Article

Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria

M. Maleki1, V. Mortezaee1, M. Hassanzad2, S. A. Mahdaviani2, M. Poorabdollah2, P. Mehrian2, N. Behnampour3, M. S. Mirenayat4, M. Abastabar1,5, M. Tavakoli1, M. T. Hedayati hedayatimt@gmail.com1,5
Download PDF

Review

Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence

A. Tonacci1, E. Nettis2, R. Asero r.asero@libero.it3, O. Rossi4, C. Tontini5, S. Gangemi6
doi: 10.23822/EurAnnACI.1764-1489.136
Download PDF

Contact

EDRA SPA

VIA G. SPADOLINI, 7

20141 MILANO – ITALY

PH. 0039 (0)2-88184.1

FAX 0039 (0)2-88184.301

WWW.EDRASPA.IT

FOLLOW US
European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024